NO20020827D0 - Piperidinalkoholer - Google Patents

Piperidinalkoholer

Info

Publication number
NO20020827D0
NO20020827D0 NO20020827A NO20020827A NO20020827D0 NO 20020827 D0 NO20020827 D0 NO 20020827D0 NO 20020827 A NO20020827 A NO 20020827A NO 20020827 A NO20020827 A NO 20020827A NO 20020827 D0 NO20020827 D0 NO 20020827D0
Authority
NO
Norway
Prior art keywords
piperidine alcohol
piperidine
alcohol
Prior art date
Application number
NO20020827A
Other languages
English (en)
Other versions
NO20020827L (no
Inventor
Helmut Pruecher
Henning Boettcher
Karl-August Ackermann
Rudolf Gottschlich
Hartmut Greiner
Juergen Harting
Gerd Bartoszyk
Christoph Seyfried
Christoph Van Amsterdam
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20020827L publication Critical patent/NO20020827L/no
Publication of NO20020827D0 publication Critical patent/NO20020827D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20020827A 1999-08-21 2002-02-20 Piperidinalkoholer NO20020827D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19939756A DE19939756A1 (de) 1999-08-21 1999-08-21 Piperidinalkohole
PCT/EP2000/007664 WO2001014332A1 (de) 1999-08-21 2000-08-08 Piperidinalkohole

Publications (2)

Publication Number Publication Date
NO20020827L NO20020827L (no) 2002-02-20
NO20020827D0 true NO20020827D0 (no) 2002-02-20

Family

ID=7919197

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020827A NO20020827D0 (no) 1999-08-21 2002-02-20 Piperidinalkoholer

Country Status (22)

Country Link
US (1) US6756370B1 (no)
EP (1) EP1202966B1 (no)
JP (1) JP2003507455A (no)
KR (1) KR20020027502A (no)
CN (1) CN1170819C (no)
AR (1) AR025333A1 (no)
AT (1) ATE268757T1 (no)
AU (1) AU760392B2 (no)
BR (1) BR0013467A (no)
CA (1) CA2382295A1 (no)
CZ (1) CZ2002499A3 (no)
DE (2) DE19939756A1 (no)
DK (1) DK1202966T3 (no)
ES (1) ES2220537T3 (no)
HU (1) HUP0203406A2 (no)
MX (1) MXPA02001750A (no)
NO (1) NO20020827D0 (no)
PL (1) PL353590A1 (no)
PT (1) PT1202966E (no)
SK (1) SK2192002A3 (no)
WO (1) WO2001014332A1 (no)
ZA (1) ZA200202291B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US7902679B2 (en) * 2001-03-05 2011-03-08 Megica Corporation Structure and manufacturing method of a chip scale package with low fabrication cost, fine pitch and high reliability solder bump
ATE460933T1 (de) * 2002-05-24 2010-04-15 Carl-Fr Coester Pharmazeutische wirkstoffkombination sowie deren verwendung
BRPI0515860B8 (pt) * 2004-12-21 2021-05-25 Hoffmann La Roche derivados de tetralin e indano, seus usos, e composição farmacêutica
CN101891672B (zh) * 2010-07-07 2012-07-11 天津大学 哌啶酮加氢反应液提纯哌啶醇产品的分离提纯方法及装置
US20120129834A1 (en) * 2010-09-17 2012-05-24 Buck Institute For Research On Aging Serotonin receptor antagonists for use in the treatment of huntington's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1280421C (en) * 1985-07-02 1991-02-19 Albert A. Carr 1,4-disubstituted piperidinyl derivatives
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
WO1991018602A1 (en) * 1990-06-01 1991-12-12 Merrell Dow Pharmaceuticals Inc. (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
NZ249286A (en) * 1992-02-13 1996-02-27 Merrell Dow Pharma Piperidine-4-ylmethyl thiophene and thiazole derivatives and pharmaceutical compositions
FR2696744B1 (fr) * 1992-10-12 1994-12-30 Logeais Labor Jacques Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
AU1301497A (en) * 1995-12-20 1997-07-14 Reinhard Laven Novel 1-phenylalkyl/alkylene-4-(.alpha.-hydroxydiphenylmethyl)-pip eridine derivatives and their use as serotonin antagonists
GB9718712D0 (en) * 1997-09-03 1997-11-12 Merck Sharp & Dohme Theraputic Agents

Also Published As

Publication number Publication date
CZ2002499A3 (cs) 2002-05-15
ATE268757T1 (de) 2004-06-15
DK1202966T3 (da) 2004-09-27
HUP0203406A2 (hu) 2003-02-28
CA2382295A1 (en) 2001-03-01
BR0013467A (pt) 2002-04-30
KR20020027502A (ko) 2002-04-13
DE50006759D1 (de) 2004-07-15
AU760392B2 (en) 2003-05-15
NO20020827L (no) 2002-02-20
ZA200202291B (en) 2003-10-29
PL353590A1 (en) 2003-12-01
CN1371365A (zh) 2002-09-25
AR025333A1 (es) 2002-11-20
PT1202966E (pt) 2004-10-29
CN1170819C (zh) 2004-10-13
JP2003507455A (ja) 2003-02-25
SK2192002A3 (en) 2002-06-04
ES2220537T3 (es) 2004-12-16
EP1202966B1 (de) 2004-06-09
DE19939756A1 (de) 2001-02-22
MXPA02001750A (es) 2003-03-27
AU7508800A (en) 2001-03-19
US6756370B1 (en) 2004-06-29
WO2001014332A1 (de) 2001-03-01
EP1202966A1 (de) 2002-05-08

Similar Documents

Publication Publication Date Title
DE60031869D1 (de) Kapazitiver druckwandler
DE60042164D1 (de) Kompaktes nadelschutzschild
ID26447A (id) Turunan eritropoietin
DE60039942D1 (de) Selbstbräununsschaum
NO20022871D0 (no) Organometallsammensetningskatalysator
DE19983871T1 (de) Fönvorrichtung
DE60025647D1 (de) Festkörperbildaufnahemvorrichtung
DE60008638D1 (de) Förderbandabstreicher
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
DE50015451D1 (de) Spülwannensystem
ID30214A (id) Turunan resorsinol
DE69935205D1 (de) Unterbrechungssteurerungssystem
DE10085008T1 (de) Oberflächenbehandlungsdüse
NO20022983D0 (no) Aminometyl-fenyl-cykloheksanonderivater
NO20020827D0 (no) Piperidinalkoholer
DE60011488D1 (de) Tuftinggarnauswahlorgan
NO20015380D0 (no) Tio-oksindolderivater
NO20005774L (no) Leketöyanordning
FI19991829A (fi) Uintianalysaattori
DE10082008D2 (de) Ausbeulgerät
NO20014261D0 (no) Histidinproteinfosfatase
ATE440824T1 (de) Nitro-sulfobenzamide
ATA107599A (de) Heizwasserbereiter
DE29908651U1 (de) Distanzscheibe
NO20022047D0 (no) Avstandselement

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application